Skip to content
Search

Latest Stories

Measles outbreak hits a new total since 2023 across England and Wales

Measles outbreak hits a new total since 2023 across England and Wales

UKHSA reports 35% surge in measles cases in London 

Despite warnings from the UK Health Security Agency (UKHSA) last year, measles outbreaks have escalated across England and Wales since the start of 2024, recording a new high in the capital city of London.

According to the latest epidemiological overview published by the health agency, there has been a significant surge in laboratory-confirmed measles cases, totaling 89 in England alone, bringing the cumulative number since October 1, 2023, to 1023.


While the crisis was previously more pronounced in the West Midlands, recent data highlights London as having the highest number of new confirmed cases, along with smaller clusters in the East Midlands and the North West.

An assessment by the UKHSA mid-last year had deemed the risk of a measles epidemic in the UK to be low.

However, it warned that due to lower vaccination coverage levels in London, a measles outbreak could potentially result in 40,000 to 160,000 cases in the capital alone.

In the four weeks since March 2024, there have been 195 laboratory-confirmed cases of measles.

While, London reported 35 per cent cases, the West Midlands reported 32 per cent, and the East Midlands reported 12 per cent.

Dr. Rob Verrecchia, UKHSA Health Protection Consultant, emphasized that measles is an "extremely infectious" yet "entirely preventable" disease.

He stressed that it takes just "one case to enter a community with low vaccination rates for measles to spread rapidly," particularly in schools and nurseries.

Verrecchia further urged parents to check their child’s Red Book to ensure they are up to date with their MMR and other routine vaccines, and to consult with their GP regarding any missed vaccinations.

Witnessing over 1,000 cases being reported since October, Dr Mary Ramsay, the UKHSA head of immunisation, said:

"Last year, UKHSA warned of the risk of a major measles outbreak in the capital if uptake of the MMR vaccine didn’t improve. NHS and local areas have been working tirelessly on improving access and working with us to encourage people to get their children vaccinated."

The COVER programme data reveals immunization coverage below 90% for some vaccines at 24 months which includes measles, mumps, and rubella (MMR1), with slight declines in uptake for various vaccines in late 2023.

Despite slight increases for some age groups, currently, coverage remains below herd immunity thresholds.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less